Search

Jill Z Mcfadden

from Baltimore, MD
Age ~44
Get Report
Also known as:
Jill M Mcfadden, Jill M Zimmerman
Related to:
Anne M Zimmerman, 49Errol D Zimmerman, 80Carolyn Zimmerman, 77Kristin Bond, 44Donn Zimmerman, 53
Connected to:
Alysa Mcfadden, 47Amber L Mcfadden, 45Ana A Mcfadden, 62Angel S Mcfadden, 43Anne Mcfadden, 86Antonio M Mcfadden, 66Ariel E Mcfadden, 33Ashlea J Mcfadden, 37Barbara M Mcfadden, 71Belinda K Mcfadden, 64

Jill Mcfadden Phones & Addresses

  • Baltimore, MD
  • Panama City, FL
  • Lynn Haven, FL
  • Baton Rouge, LA
  • Prairieville, LA
  • New Haven, CT
  • Spartanburg, SC
  • 6803 Harrowdale Rd APT T2, Baltimore, MD 21209

Resumes

Resumes

Jill Mcfadden Photo 1

Jill Mcfadden

View page
Jill Mcfadden Photo 2

Jill Mcfadden

View page
Location:
United States
Jill Mcfadden Photo 3

Jill Mcfadden

View page
Jill Mcfadden Photo 4

Jill Mcfadden

View page
Jill Mcfadden Photo 5

Regional Director

View page
Position:
Southern Regional Director at EurAupair International
Location:
Laguna Beach, California
Industry:
Nonprofit Organization Management
Work:
EurAupair International since Aug 2009
Southern Regional Director
RH Clothing Jan 2008 - Aug 2009
Assistant Buyer/Store Merchandiser
Stairways Behavioral Health 2007 - 2008
Therapeutic Staff Support
Hanyang University 2005 - 2006
Language Instructor
Stairways Behavioral Health 2003 - 2005
Therapeutic Staff Support
Education:
Edinboro University of Pennsylvania 1998 - 2003

Publications

Us Patents

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20060241177, Oct 26, 2006
Filed:
Jul 1, 2003
Appl. No.:
10/519804
Inventors:
Susan Medghalchi - Baltimore MD, US
Jagan Thupari - Baltimore MD, US
Craig Townsend - Baltimore MD, US
Jill McFadden - Baltimore MD, US
International Classification:
A61K 31/365
C07D 305/12
US Classification:
514471000, 514473000, 549321000
Abstract:
Pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IX: R═H, or C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, ═CHR, —C(O)OR, —C(O)R, —CHC(O)OR, CHC(O)NHR, where Ris H or C-Calkyl, cycloalkyl, or alkenyl; R═C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl; X═—OR, or NHR, Where Ris H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, the Rgroup optionally containing a carbonyl group, a carboxyl group, a carboxyamide group, an alcohol group, or an ether group, the Rgroup further optionally containing one or more halogen atoms; with the proviso that when Ris ═CH, then Xis not OH. Also disclosed are compounds within the scope of the formula IX, as well as uses of the pharmaceutical compositions for weight loss, anti-microbial and anti-cancer applications, inhibition of fatty acid synthase and neuropeptide-Y, and the stimulation of the activity of carnitine palmitoyl transferase-1.

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20060247302, Nov 2, 2006
Filed:
Jul 9, 2003
Appl. No.:
10/520505
Inventors:
Francis Kuhajda - Baltimore MD, US
Susan Medghalchi - Baltimore MD, US
Jill McFadden - Baltimore MD, US
Jagan Thupari - Baltimore MD, US
Assignee:
FASgen, Inc. - Baltimore MD
Johns Hopkins University - Baltimore MD
International Classification:
A61K 31/381
C07D 333/32
US Classification:
514445000, 549062000
Abstract:
A pharmaceutical composition comprising a phamaceurtical diluent and a compound of formula IV wherein R═H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, —CHOR, —C(O)R, —CO(O)R, —C(O)NRR, —CHC(O)R, or —CHC(O)NHR, where Rand Rare each independently H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing one or more halogen atoms. R═—OH, —OR, —OCHC(O)R, —OCHC(O)NHR, —OC(O)R, —OC(O)OR, —OC(O)NHNH—R, or —OC(O)NRR, where Rand Rare each independently H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where Rand Rcan each optionally contain halogen atoms; Rand R, the same or different from each other, are C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat microbially-based infections, to inhibit neuropeptide-Y and/or fatty acid synthase, and to stimulate CPT-1.

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20100029752, Feb 4, 2010
Filed:
Jul 26, 2006
Appl. No.:
12/309418
Inventors:
Francis P. Kuhajda - Baltimore MD, US
Craig A. Townsend - Baltimore MD, US
Susan M. Medghalchi - Baltimore MD, US
Jill M. McFadden - Baltimore MD, US
International Classification:
A61K 31/381
C07D 307/34
C07D 307/26
A61P 35/00
US Classification:
514444, 549479, 549473, 514445
Abstract:
A pharmaceutical composition containing a pharmaceutical diluent and a compound of formula II: wherein: R═H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, —C(O)R, where Ris H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms, or —OH, —ORor —NR, where Ris H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms; R=—OR, —NR, —NH—NH—Rwhere Ris H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, allyl, or alkylaryl, optionally containing halogen atoms; R═H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, or —CHC(O)R, where Ris ORand NR, where R═H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, allyl, or alkylaryl and can optionally contain halogen atoms. Also included in the invention are methods of using the pharmaceutical compositions and the chemical compounds used in the compositions.

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20100029761, Feb 4, 2010
Filed:
Jul 26, 2006
Appl. No.:
12/309419
Inventors:
Francis P. Kuhajda - Baltimore MD, US
Craig A. Townsend - Baltimore MD, US
Susan M. Medghalchi - Baltimore MD, US
Jill M. McFadden - Baltimore MD, US
International Classification:
A61K 31/341
C07D 307/04
C07D 307/26
A61P 3/04
US Classification:
514473, 549477
Abstract:
A pharmaceutical diluent and a compound of formula VI: wherein: R10=H, or C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms; R11=H3 or C]-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms; R12=H, or C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms, —C(O)R13, where R13 is H, Ci-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms, or —OH, —OR14 or —NR14, where R14 is H, C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing halogen atoms.

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20100120901, May 13, 2010
Filed:
Jan 13, 2010
Appl. No.:
12/686691
Inventors:
Francis P. Kuhajda - Baltimore MD, US
Susan M. Medghalchi - Baltimore MD, US
Jill M. McFadden - Baltimore MD, US
Jagan Thupari - Baltimore MD, US
Craig A. Townsend - Baltimore MD, US
Assignee:
FASGEN,INC - Baltimore MD
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 31/381
C07D 333/32
A61P 3/00
A61P 31/00
US Classification:
514445, 549 62, 549 65, 549 66
Abstract:
A pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IV wherein R=H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, —CHOR, —C(O)R, —CO(O)R, —C(O)NRR, —CHC(O)R, or —CHC(O)NHR, where Rand Rare each independently H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing one or more halogen atoms. R=—OH, —OR, —OCHC(O)R, —OCHC(O)NHR, —OC(O)R, —OC(O)OR, —OC(O)NHNH—R, or —OC(O)NRR, where Rand Rare each independently H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where Rand Rcan each optionally contain halogen atoms; Rand R, the same or different from each other, are C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat microbially-based infections, to inhibit neuropeptide-Y and/or fatty acid synthase, and to stimulate CPT-1.

Novel Compounds, Pharmaceutical Compositions Containing Same, And Methods Of Use For Same

View page
US Patent:
20110288052, Nov 24, 2011
Filed:
Jun 2, 2009
Appl. No.:
12/995663
Inventors:
Craig A. Townsend - Baltimore MD, US
Kandasamy Subburaj - Baltimore MD, US
Jill Marie McFadden - Chapel Hill NC, US
International Classification:
C07D 333/32
C07D 409/12
C07D 413/12
A61K 31/5377
A61P 31/00
A61K 31/496
A61K 31/4535
A61P 35/04
A61P 3/04
A61K 31/381
A61K 31/69
US Classification:
514 64, 549 66, 514445, 514444, 549 60, 549 59, 544146, 5142315, 549 4, 544379, 51425213, 514326, 546213
Abstract:
The class compounds of the present invention may be represented by Formula (I), wherein X may be O, S, or N. Rand Rare independently either H, C-Calkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Rand Rare independently either H, an aryl group, a heteroaryl group, and a heterocyclic ring group having 4 to 6 carbon atoms, wherein the aryl, heteroaryl, and heterocyclic moieties are optionally substituted with one or more of a first substitution group defined herein. In a further embodiment, Rand Ralong with the atoms and bonds to which they are attached, form an optionally substituted 5-7 membered ring having at least one nitrogen atom within the ring structure.
Control profile
Jill Z Mcfadden from Baltimore, MD, age ~44 Get Report